Co-delivery strategies based on multifunctional nanocarriers for cancer therapy
Hao Chen1, Ying Zhao, Hai Wang
1Eye Hospital of Wenzhou Medical College, Key Laboratory for Ophthalmology & Optometry of Zhejiang Provence, Wenzhou, China.
Current Drug Metabolism
|March 3, 2012
Summary
Nanotechnology enables co-delivery of multiple chemotherapy drugs to enhance cancer treatment efficacy and reduce side effects. Multifunctional nanocarriers offer combined diagnosis and therapy, highlighting the need for biocompatible designs.
Area of Science:
- Oncology
- Nanotechnology
- Drug Delivery
Background:
- Chemotherapy is a primary cancer treatment but causes significant toxicity to normal tissues, limiting its use.
- Drug resistance and tumor heterogeneity necessitate advanced therapeutic strategies.
Purpose of the Study:
- To review current nanotechnology-based co-delivery strategies for cancer therapy.
- To highlight the potential of multifunctional nanocarriers for combined diagnosis and treatment.
- To emphasize the need for developing biocompatible and low-toxicity nanocarrier systems.
Main Methods:
- Review of current literature on nanotechnology-enabled drug delivery systems for cancer.
- Analysis of strategies for co-delivering multiple chemotherapeutic agents.
- Discussion of multifunctional nanocarriers for theranostics (therapy and diagnostics).
Main Results:
- Nanotechnology platforms allow simultaneous delivery of multiple chemotherapeutic agents, targeting diverse tumor cell pathways.
- Multifunctional nanocarriers can integrate diagnostic agents (e.g., MRI contrast agents, fluorescent probes) for simultaneous cancer diagnosis and therapy.
- Co-delivery strategies offer potential for enhanced therapeutic efficacy and reduced cytotoxicity compared to conventional chemotherapy.
Conclusions:
- Nanotechnology-based co-delivery represents a promising approach to overcome chemotherapy limitations.
- Development of novel, biocompatible, and low-toxicity nanocarriers is crucial for clinical translation.
- Further research into the adverse effects of nanocarriers is warranted to ensure patient safety.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...